Used IMED / ALARIS Gemini PC-1 #9353867 for sale

IMED / ALARIS Gemini PC-1 syringe pump is an advanced ambulatory infusion device designed to provide precise, safe, and reliable infusion pump therapy for various clinical settings. The pump is capable of running both continuous and programmable intermittent infusions. This compact and lightweight pump offers a wide range of infusion rates and duration capabilities for most critical care and homecare applications. IMED Gemini PC-1 pump features a three-in-one programmable function, which includes infusion, patient data logging, and medication events log. This feature allows users to customize infusion profiles for each patient, as well as monitor infused and discontinued medications from the device's intuitive interface. The device comes equipped with a 10-position rotary encoder, allowing for precise selection of infusion rates. The pump also includes an antimicrobial housing that helps protect it from contaminants. ALARIS Gemini PC-1 is capable of infusing a variety of fluids, including medication, saline, insulin, hypertonic solutions, and resuscitation solution. The device can be powered via an AC power adapter or a 12V car adapter, offering portability and flexibility. It also features a visual display that shows real-time values and enable users to easily monitor pump performance. The device also meets IEC 60068-3 requirements and is suitable for use in both hospital and homecare settings. It is equipped with two safety lockouts to help prevent unintentional programming changes or misadministration of treatments. Gemini PC-1 is also equipped with a temporal audit trail that records all user actions and important device events. Overall, IMED / ALARIS Gemini PC-1 is a reliable, versatile, and user-friendly infusion pump that is well suited for both clinical and homecare settings. Its portability, safety measures, and real-time monitoring capabilities allow users to easily customize and manage a wide array of infusion treatments, for the most effective and safest outcomes.